Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03646019|
Recruitment Status : Not yet recruiting
First Posted : August 24, 2018
Last Update Posted : August 24, 2018
|Condition or disease|
|Coronary Artery Disease Paraoxanase 1 Thiobarbituric Acid Reactive Substances Thiol Groups|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Official Title:||Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.|
|Estimated Study Start Date :||September 2018|
|Estimated Primary Completion Date :||March 2019|
|Estimated Study Completion Date :||March 2019|
|Normal coronary arteries|
|Non significant coronary artery disease|
|Significant coronary artery disease|
- The presence and severity of coronary artery disease assessed by a cardiac CT scan / coronary angiography. [ Time Frame: 7 days ]The presence of coronary artery disease is defined as the presence of any atherosclerotic plaque leading to any percentage of coronary artery stenosis. The severity of coronary artery disease is defined either as significant or non significant. A Non significant coronary artery disease is defined as any coronary artery stenosis less than or equal to 49%. A Significant coronary artery disease is defined as any coronary artery stenosis more than 49%.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03646019
|Contact: Tony Hayek, professor||+ firstname.lastname@example.org|
|Contact: Dima Namouz, Doctor||+ email@example.com|